• Neumann JT, Twerenbold R, Weimann J, Ballantyne CM, Benjamin EJ, Costanzo S, de Lemos JA, deFilippi CR, Di Castelnuovo A, Donfrancesco C, Dörr M, Eggers KM, Engström G, Felix SB, Ferrario MM, Gansevoort RT, Giampaoli S, Giedraitis V, Hedberg P, Iacoviello L, Jørgensen T, Kee F, Koenig W, Kuulasmaa K, Lewis JR, Lorenz T, Lyngbakken MN, Magnussen C, Melander O, Nauck M, Niiranen TJ, Nilsson PM, Olsen MH, Omland T, Oskarsson V, Palmieri L, Peters A, Prince RL, Qaderi V, Vasan RS, Salomaa V, Sans S, Smith JG, Söderberg S, Thorand B, Tonkin AM, Tunstall-Pedoe H, Veronesi G, Watanabe T, Watanabe M, Zeiher AM, Zeller T, Blankenberg S, Ojeda F.

    Prognostic value of cardiovascular biomarkers in the population.

    JAMA. 2024 May 13. Epub ahead of print PubMed-ID: 38739396. DOI: 10.1001/jama.2024.5596.


  • Dahle N, Ärnlöv J, Leppert J, Hedberg P.

    Nondipping blood pressure pattern predicts cardiovascular events and mortality in patients with atherosclerotic peripheral vascular disease

    Vascular Medicine. 2023;April 12; Epub ahead of print. PubMed-ID: 37036102. DOI: 10.1177/1358863X231161655.

  • Skau E, Wagner P, Leppert J, Ärnlöv J, Hedberg P.

    Are the results from a multiplex proteomic assay and a conventional immunoassay for NT-proBNP and GDF-15 comparable?

    Clin Proteomics. 2023;20:5. PubMed-ID: 36694116. DOI: 10.1186/s12014-023-09393-1.

  • Lodder P, Wicherts JM, Antens M, Albus C, Bessonov IS, Condén E, Dulfer K, Gostoli S, Grande G, Hedberg P, Herrmann-Lingen C, Jaarsma T, Koo M, Lin P, Lin TK, Meyer T, Pushkarev G, Rafanelli C, Raykh OI, Schaan de Quadros A, Schmidt M, Sumin AN, Utens EMWJ, van Veldhuisen DJ, Wang Y, Kupper N.

    Type D personality as a risk factor for adverse outcome in patients with cardiovascular disease: An individual patient-data meta-analysis.

    Psychosom Med. 2023;85:188. PubMed-ID: 36640440. DOI: 10.1097/psy.0000000000001164.


  • Nilsson G, Leppert J, Öhrvik J.

    Enigma of the cholesterol paradox in acute myocardial infarction: lessons from an 8-year follow-up of all-cause mortality in an age-matched and sex-matched case–control study with controls from the patients’ recruitment area.

    BMJ Open. 2022;12:e057562. PubMed-ID: 35896296. DOI: 10.1136/bmjopen-2021-057562.


  • Dahle N, Skau E, Leppert J, Ärnlöv J, Hedberg P.

    Poorly controlled ambulatory blood pressure in outpatients with peripheral arterial disease.

    Upsala J Med Sci. 2021;126:e7609. PubMed-ID: 33995892. DOI: 10.48101/ujms.v126.7609.

  • Lind L, Gigante B, Borné Y, Feldreich T, Leppert J, Hedberg P, Östgren CJ, Nyström FH, Sundström J, Ärnlöv J, Baldassarre D, Tremoli E, Veglia F, Hamsten A, O’Donnell CJ, Franceschini N, Orho-Melander M, Nilsson J, Melander O, Engström G, Mälarstig A.

    Plasma protein profile of carotid artery atherosclerosis and atherosclerotic outcomes – Meta-analyses and Mendelian randomization analyses.

    Arterioscer Thromb Vasc Biol. 2021;41:1777. PubMed-ID: 33657885. DOI: 10.1161/ATVBAHA.120.315597.

  • Rydell A, Nowak C, Janson C, Lisspers K, Ställberg B, Iggman D, Leppert J, Hedberg P, Sundström J, Ingelsson E, Lind L, Ärnlöv J.

    Plasma proteomics and lung function in four community-based cohorts.

    Respir Med. 2021;176:106282. PubMed-ID: 33310204. DOI: 10.1016/j.rmed.2020.106282.


  • Feldreich T, Nowak C, Carlsson A, Östgren C-J, Nyström F, Sundström J, Carrero-Roig J-J, Leppert J, Hedberg P, Giedraitis, V, Lind L, Cordeiro A, Ärnlöv J.

    The association between plasma proteomics and incident cardiovascular disease identifies MMP- 12 as a promising cardiovascular risk marker in patients with chronic kidney disease.

    Atherosclerosis. 2020;307:11. PubMed-ID: 32702535. DOI: 10.1016/j.atherosclerosis.2020.06.013.

  • Skau E, Henriksen E, Leppert J, Wagner P, Ärnlöv J, Hedberg P.

    Targeted multiplex proteomics for prediction of all-cause mortality during long-term follow-up in outpatients with peripheral arterial disease.

    Atherosclerosis. 2020;311:143. PubMed-ID: 32711845. DOI: 10.1016/j.atherosclerosis.2020.06.015.


  • Cederlöf ET, Johnston N, Leppert J, Hedberg P, Lindahl B, Christersson C.

    Do self-reported pregnancy complications add to risk evaluation in older women with established cardiovascular disease?

    BMC Womens Health. 2019;19:160. PubMed-ID: 31842885. DOI: 10.1186/s12905-019-0851-x.

  • Velders MA, , Calais F, Dahle N, Fall T, Hagström E, Leppert J, Nowak C, Tenerz Å, Ärnlöv J, Hedberg P.

    Cathepsin D improves the prediction of undetected diabetes in patients with myocardial infarction.

    Upsala J Med Sci. 2019;124:187. PubMed-ID: 31429631. DOI: 10.1080/03009734.2019.1650141.

  • Henriksen E, Selmeryd J, Hedberg P.

    Associations of left atrial volumes and Doppler filling indices with left atrial function in acute myocardial infarction.

    Clin Physiol Funct Imaging. 2019;39:85. PubMed-ID: 29961999. DOI: 10.1111/cpf.12533.


  • Nowak C, Carlsson AC, Östgren CJ, Nyström FH, Alam M, Feldreich T, Sundström J, Carrero J-J, Leppert J, Hedberg P, Henriksen E, Cordeiro AC, Giedraitis V, Lind L, Ingelsson E, Fall T, Ärnlöv J.

    Multiplex proteomics for prediction of major cardiovascular events in type 2 diabetes.

    Diabetologia. 2018;61:1748. PubMed-ID: 29796748. DOI: 10.1007/s00125-018-4641-z.

  • Nilsson G, Hedberg P, Leppert J, Öhrvik J.

    Basic anthropometric measures in acute myocardial infarction patients and individually sex- and age-matched controls from the general population.

    J Obesity. 2018:3839482. PubMed-ID: 30533220. DOI: 10.1155/2018/3839482.

  • Doerstling S, Hedberg P, Öhrvik J, Leppert J, Henriksen E.

    Growth differentiation factor 15 in a community-based sample: age-dependent reference limits and prognostic impact.

    Upsala J Med Sci. 2018;123:86. PubMed-ID: 29714603. DOI: 10.1080/03009734.2018.1460427.

  • Calais F, Eriksson-Östman M, Hedberg P, Rosenblad A, Leppert J, Fröbert O.

    Incremental prognostic value of coronary and systemic atherosclerosis after myocardial infarction.

    Int J Cardiol. 2018;261:6. PubMed-ID: 29657058. DOI: 10.1016/j.ijcard.2018.02.035.

  • Selmeryd J, Henriksen E, Dalen H, Hedberg P.

    Derivation and evaluation of age-specific multivariate reference regions to aid in identification of abnormal filling patterns: the HUNT and VaMIS studies.

    JACC Cardiovasc Imaging. 2018;11:400. PubMed-ID: 28734926. DOI: 10.1016/j.jcmg.2017.04.019.

  • Hysing P, Jonason T, Leppert J, Hedberg P.

    Prevalence and prognostic impact of electrocardiographic abnormalities in outpatients with extracardiac artery disease.

    Clin Physiol Funct Imaging. 2018;38:823. PubMed-ID: 29171136. DOI: 10.1111/cpf.12488.


  • Skau E, Henriksen E, Wagner P, Hedberg P, Siegbahn A, Leppert J.

    GDF-15 and TRAIL-R2 are powerful predictors of long-term mortality in patients with acute myocardial infarction.

    Eur J Prev Cardiol. 2017;24:1576. PubMed-ID: 28762762. DOI: 10.1177/2047487317725017.

  • Eriksson Östman M, Calais F, Rosenblad A, Fröbert O, Leppert J, Hedberg P.

    Prognostic impact of subclinical or manifest extracoronary artery diseases after acute myocardial infarction.

    Atherosclerosis. 2017;263:53. PubMed-ID: 28599258. DOI: 10.1016/j.atherosclerosis.2017.05.027.

  • Condén E, Rosenblad A, Wagner P, Leppert J, Ekselius L, Åslund C.

    Is type D personality an independent risk factor for recurrent myocardial infarction or all-cause mortality in post-acute myocardial infarction patients?

    Eur J Prev Cardiol. 2017;24:522. PubMed-ID: 28071958. DOI: 10.1177/2047487316687427.

  • Hedberg P, Selmeryd J, Leppert J, Henriksen E.

    Long-term prognostic impact of left atrial volumes and emptying fraction in a community-based cohort.

    Heart. 2017;103:687. PubMed-ID: 28067203. DOI: 10.1136/heartjnl-2016-310242.


  • Condén E, Rosenblad A.

    Insomnia predicts long-term all-cause mortality after acute myocardial infarction: a prospective cohort study.

    Int J Cardiol. 2016;215:217. PubMed-ID: 27128534. DOI: 10.1016/j.ijcard.2016.04.080.

  • Selmeryd J, Henriksen E, Leppert J, Hedberg P.

    Interstudy heterogeneity of definitions of diastolic dysfunction severely affects reported prevalence.

    Eur Hear J – Cardiovasc Imaging. 2016;17:892. PubMed-ID: 26374880. DOI: 10.1093/ehjci/jev211.

  • Hedberg P, Selmeryd J, Leppert J, Henriksen E.

    Left atrial minimum volume is more strongly associated with N-terminal pro-B-type natriuretic peptide than the left atrial maximum volume in a community-based sample.

    Int J Cardiovasc Imaging. 2016;32:417. PubMed-ID: 26498654. DOI: 10.1007/s10554-015-0800-1.


  • Henriksen E, Selmeryd J, Leppert J, Hedberg P.

    Echocardiographic assessment of maximum and minimum left atrial volumes: a population-based study of middle-aged and older subjects without apparent cardiovascular disease.

    Int J Cardiovasc Imaging. 2015;31:57. PubMed-ID: 25212378. DOI: 10.1007/s10554-014-0533-6.


  • Hedberg P, Hammar C, Selmeryd J, Viklund J, Leppert J, Hellberg A, Henriksen E.

    Left ventricular systolic dysfunction in outpatients with peripheral atherosclerotic vascular disease: prevalence and association with location of arterial disease.

    Eur J Heart Fail. 2014;16:625. PubMed-ID: 24771615. DOI: 10.1002/ejhf.95.

  • Condén E, Rosenblad A, Ekselius L, Åslund C.

    Prevalence of type D personality and factorial and temporal stability of the DS14 after myocardial infarction in a Swedish population.

    Scand J Psychol. 2014;55:601. PubMed-ID: 25243796. DOI: 10.1111/sjop.12162.

  • Calais F, Fröbert O, Rosenblad A, Hedberg P, Wachtell K, Leppert J.

    Leisure-time physical inactivity and risk of myocardial infarction and all-cause mortality: a case-control study.

    Int J Cardiol. 2014;177:599. PubMed-ID: 25223818. DOI: 10.1016/j.ijcard.2014.08.137.